Evidence map›Paper›PMID 21742019›Full record

ArticleNeuroscience2011

Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development.

J D Sanders, H K Happe, D B Bylund, L C Murrin

Abstract read
In one paragraph

Article in Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Negative relationship between brain αExperimental brain research · 2020
    Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

J D SandersDepartment of Pharmacology and Experimental Neuroscience, 985800 Nebraska Medical Center, Omaha, NE 68198-5800, USA.
H K Happe
D B Bylund
L C Murrin
Nebraska Medical Center · USCreighton University · US

Funding

Adrenergic Receptors During Periadolescent DevelopmentR01MH064772 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BYLUND, DAVID B · 2002 to 2005
$1.3M
DEVELOPMENT OF CNS ALPHA-2 ADRENERGIC RECEPTOR SUBTYPESR01NS033194 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI MURRIN, LEONARD CHARLES · 1996 to 1999
–
NIMH NIH HHS MH64772NIMH NIH HHS R01 MH064772NINDS NIH HHS NS33194NINDS NIH HHS R01 NS033194
6 · The paper itself

Abstract

Alpha-2 adrenergic receptors (A2AR) regulate multiple brain functions and are enriched in developing brain. Studies demonstrate norepinephrine (NE) plays a role in regulating brain maturation, suggesting it is important in A2AR development. To investigate this we employed models of NE absence and excess during brain development. For decreases in NE we used N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4), a specific noradrenergic neurotoxin. Increased noradrenergic terminal density was produced by methylazoxymethanol acetate (MAM) treatment. A2AR density was assayed with [(3)H]RX821002 autoradiography. DSP4 lesions on postnatal day (PND) 3 produce A2AR decreases in many regions by PND 5. A2AR recover to control levels by PND 15 and 25 and there is no further change in total receptor density. We also assayed A2AR in brains lesioned with DSP4 on PND 13, 23, 33 and 43 and harvested 22 days post-lesion. A2AR levels remain similar to control at each of these time points. We examined A2AR functionality and high affinity state with epinephrine-stimulated [(35)S]GTPγS and [(125)I]p-iodoclonidine autoradiography, respectively. On PND 25, control animals and animals lesioned with DSP4 on PND 3 have similar levels of [(35)S]GTPγS incorporation and no change in high affinity state. This is in contrast to increases in A2AR high affinity state produced by DSP4 lesions of mature brain. We next investigated A2AR response to increases in norepinephrine levels produced by MAM. In contrast to DSP4 lesions, increasing NE results in a large increase in A2AR. Animals treated with MAM on gestational day 14 had cortical [(3)H]RX821002 binding 100-200% greater than controls on PND 25, 35, 45, 55 and 65. These data indicate that NE regulation of A2AR differs in developing and mature brain and support the idea that NE regulates A2AR development and this has long term effects on A2AR function.

Indexed as

AnimalsAnimals, NewbornAutoradiographyBenzylaminesBrainChromatography, High Pressure LiquidNeurogenesisNeurotoxinsNorepinephrineNorepinephrine Plasma Membrane Transport ProteinsRatsRats, Sprague-DawleyReceptors, Adrenergic, alpha-2Adra2a protein, ratBenzylaminesDSP 4NeurotoxinsNorepinephrineNorepinephrine Plasma Membrane Transport ProteinsReceptors, Adrenergic, alpha-2

Identifiers

PMID21742019
PMCPMC3166411
OpenAlexW2081845976

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.